SCHEMBL5653811

SCHEMBL5653811

CCCCCCCCCCCCCC[NH+](C)CCCCCCCCCCCCCC.Oc1ccccc1[B-](c1c(F)c(F)c(F)c(F)c1F)(c1c(F)c(F)c(F)c(F)c1F)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
NAAA Q02083 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATM Q13315 1/20 0.33
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX5 P09917 1/20 0.31
TYR P14679 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
BID P55957 3/20 0.30
MCL1 Q07820 3/20 0.30
BCL2L1 Q07817 2/20 0.30
BAK1 Q16611 2/20 0.30
KAT8 Q9H7Z6 2/20 0.30
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656345 1.00 MEN1 (0.33) MEN1MAPTHTTKMT2ANAAA
SCHEMBL5872296 1.00 MEN1 (0.33) MEN1MAPTHTTKMT2ANAAA
Dymanthine SCHEMBL1276492 0.92 DNM1 (0.40) MEN1MAPTHTTKMT2ANAAA
SCHEMBL1276666 0.90 MEN1 (0.35) MEN1MAPTHTTKMT2ANAAA
SCHEMBL6462737 0.87 NAAA (0.32) MEN1MAPTHTTKMT2ANAAA
SCHEMBL30240774 0.86 BID (0.31) MEN1MAPTHTTKMT2ANAAA
SCHEMBL5655348 0.86 BID (0.31) MEN1MAPTHTTKMT2ANAAA
SCHEMBL29661112 0.83 MEN1 (0.33) MEN1MAPTHTTKMT2ANAAA
SCHEMBL5655310 0.82 MGLL (0.30)
SCHEMBL5656636 0.81 PTGS1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376406-B1 COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS THE DOW CHEMICAL COMPANY 2002-04-23 US claimed
US-7098356-B2 Substituted indenyl metal complexes and polymerization process DOW GLOBAL TECHNOLOGIES INC. (US) 2006-08-29 US disclosed
US-7074865-B2 Azaborolyl group 4 metal complexes, catalysts and olefin polymerization process DOW GLOBAL TECHNOLOGIES INC. (US) 2006-07-11 US disclosed
US-20050119114-A1 Azaborolyl group 4 metal complexes, catalysts and olefin polymerization process DOW GLOBAL TECHNOLOGIES LLC 2005-06-02 US disclosed
US-6872844-B2 Metal complexes containing acetylenic ligands, polymerization catalysts and addition polymerization process THE DOW CHEMICAL COMPANY (US) 2005-03-29 US disclosed
US-6825295-B2 COORDINATION POLYMERIZATION CATALYST DOW GLOBAL TECHNOLOGIES INC. 2004-11-30 US disclosed
US-6806327-B2 POLYMERIZATION CATALYSTS SUCH AS (8-METHYLENE-1,8-DIHYDRODIBENZO(E,H)AZULEN-1-YL)-N-(1,1-DIMETHYLETHYL) DIMETHYLSILANAMIDE TITANIUM (II) 1,4-DIPHENYL-1,2-BUTADIENE DOW GLOBAL TECHNOLOGIES INC. 2004-10-19 US disclosed
US-20040010102-A1 Bridged ylide group containning metal complexes ROBERT BOSCH GMBH (DE) 2004-01-15 US disclosed
US-20020183464-A1 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process DOW GLOBAL TECHNOLOGIES LLC 2002-12-05 US disclosed
US-20020165329-A1 Heat-resistant group 4 metal metallecenes having a nitrogen with aliphatic or cycloaliphatic moiety substituted with aryl group(s)and a silane bridge; high-molecular weight ethylene-alpha olefin copolymers; high concentration of comonomer KLOSIN JERZY (US) 2002-11-07 US disclosed
US-20020151662-A1 Substituted polycyclic, fused ring compounds, metal complexes and polymerization process DOW GLOBAL TECHNOLOGIES LLC 2002-10-17 US disclosed
US-6376406-B1 COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS THE DOW CHEMICAL COMPANY 2002-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183464-A1 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process SOD1, AOC3, PPOX MEN1 4838/4885MAPT 1418/4885HTT 1764/4885
US-20020165329-A1 Heat-resistant group 4 metal metallecenes having a nitrogen with aliphatic or cycloaliphatic moiety substituted with aryl group(s)and a silane bridge; high-molecular weight ethylene-alpha olefin copolymers; high concentration of comonomer B2M, WEE2, WASF2 MEN1 2455/4885MAPT 2203/4885HTT 3508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.